SIGA TECHNOLOGIES INC
SIGA · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Marshall Joseph W III: Form 4
Insider disclosure · Filed · Report period 09 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- SIGA · 826917106 - Common Stock
Company details and SEC sources
CIK 0001010086 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- SIGA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 31 East 62 Nd Street, New York, NY, 10065
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- SIGA PHARMACEUTICALS INC (to 25 May 2000)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields